¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¼ö»óÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ
 ÀϹݿ¬Á¦ ¹ßÇ¥ À¯ÀÇ»çÇ×

ÀϹݿ¬Á¦ ¹ßÇ¥ÀÚ´Â ¹Ýµå½Ã ¹ßÇ¥ ½½¶óÀ̵å(ÆÄ¿öÆ÷ÀÎÆ®)¸¦ »çÀü¿¡ Á¦ÃâÇÏ¼Å¾ß ¹ßÇ¥°¡ °¡´ÉÇÕ´Ï´Ù.
½½¶óÀ̵带 ±âÇÑ ³»¿¡ Á¦ÃâÇÏÁö ¾ÊÀ» °æ¿ì¿¡´Â ¹ßÇ¥ºÒ°¡´ÉÀ¸·Î °£ÁÖÇÕ´Ï´Ù.
¹ßÇ¥ ½½¶óÀ̵å¼ö´Â 15¸Å À̳»·Î 1Àå ´ç 10ÁÙ À̳»·Î Á¦ÀÛÇϽô °ÍÀ» ±ÇÀåÇϸç, ÁöÁ¤µÈ ¹ßÇ¥½Ã°£(7ºÐ ¹ßÇ¥-3ºÐ ÁúÀÇÀÀ´ä)À» Á¤È®È÷
ÁöÄÑÁֽñ⠹ٶø´Ï´Ù.


1. ÆÄÀÏ Á¦Ã⸶°¨ÀÏ : 9¿ù 22ÀÏ(¿ù)
2. ÆÄÀÏ ÇüÅ : ÆÄ¿öÆ÷ÀÎÆ®
3. Á¦Ãâ ¹æ¹ý : office@ksog.org
¸ðüžÆÀÇÇР  /    »ý½Ä³»ºÐºñÇР  /    ºÎÀÎÁ¾¾çÇР  /    ÀϹݺÎÀΰúÇÐ
ÀϹݿ¬Á¦ : ¸ðüžÆÀÇÇÐ - ÀϽà : 2014³â 9¿ù 26ÀÏ (±Ý)
- Àå¼Ò : ¿¡¸Þ¶öµåȦ A[3F]
OB1-OB4 (08:20~09:00) ÁÂÀå : ½ÅÁ¾Ã¶(°¡Å縯ÀÇ´ë)
OB108:20~08:30 ¹ÚÁ¤¿¬
¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú
Prevalence of gestational diabetes according to different oral glucose tolerance tests in the Korean population
OB208:30~08:40 Á¶Èñ¿µ
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
Association between gestational fasting plasma glucose and maternal and perinatal outcomes in gestational diabetes mellitus patients
OB308:40~08:50 ºÎÇý¿¬
ÇѾç´ëÇб³º´¿ø »êºÎÀΰú
Nonlinear and linear indices of fetal heart rate in large for gestational age fetuses
OB408:50~09:00 ¾È±âÈÆ
°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú
The Safety of Progesterone for Treatment of Preterm Labor: Meta-analysis
OB5-OB8 (09:00~09:40) ÁÂÀå : ±è»çÁø(°¡Å縯ÀÇ´ë)
OB509:00~09:10 Á¤Àº¿µ
¼­¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú
Àڱøñ¹«·ÂÁõ »ê¸ð¿¡¼­ ÀÀ±Þ Àڱøñ¿øÇü¹­À½¼ú ½ÃÇà ÈÄ ÇÁ·Î°Ô½ºÅ×·Ð Ãß°¡ Ä¡·áÀÇ Á¶»ê ¿¹¹æ È¿°ú
OB609:10~09:20 ÀÌÇýÁ¤
¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú
Gestational age at delivery and neonatal outcome in uncomplicated twin pregnancies; what is the optimal age for delivery according to chorionicity?
OB709:20~09:30 Á¶ÁÖÇö
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
Should we adjust the cut-off value for 50g glucose challenge test(GCT) higher in twin pregnancy?
OB809:30~09:40 Á¶±ÝÁØ
°í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú
Gestational diabetes and pre-pregnancy factors as long-term risk factors for developing diabetes mellitus
OB9-OB12 (09:40~10:20) ÁÂÀå : ±è ¾Ï(¿ï»êÀÇ´ë)
OB909:40~09:50 ÃÖ¼ö¶õ
ÀÎÇÏ´ëÇб³º´¿ø »êºÎÀΰú
Secretory Leukocyte Protease Inhibitor and Neutrophil Elastase in the cervical mucus with short cervical length
OB1009:50~10:00 ÀÌÁØÈ£
¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú
Maternal vascular underperfusion: clinical implications in a preterm birth cohort
OB1110:00~10:10 ±è¹ÎÇü
Placental microRNAs as potential biomarkers for noninvasive detection of trisomy 21
OB1210:10~10:20 ³ª¼ºÈÆ
°­¿ø´ëÇб³º´¿ø »êºÎÀΰú
Expansion by basic fibroblast growth factor of non-enzymatically isolated perivascular cells from human umbilical cord
OB13-OB16 (11:00~11:40) ÁÂÀå : ¼ÕÀμ÷(°Ç±¹ÀÇ´ë)
OB1311:00~11:10 õÁÖ¿µ
°¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø »êºÎÀΰú
Effects of ECM Protein Mimetics on Adhesion and Proliferation of Chorion Derived Mesenchymal Stem Cells
OB1411:10~11:20 ¾î°æÁø
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
A Prospective Study on the maternal serum PlGF and PAPP-A identified at the first trimester as parameters of subsequently developed pre-eclampsia and SGA
OB1511:20~11:30 ÀÌû¾Æ
¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú
Clinical characteristics of pregnancies complicated by congenital myotonic dystrophy
OB1611:30~11:40 ¹Ú¼­¿¬
Â÷ÀÇ°úÇдëÇб³ °­³²Â÷º´¿ø »êºÎÀΰú
Analysis of global gene expression through the amniotic fluid cell-free fetal RNA according to the gestational age
OB17-OB20 (11:40~12:20) ÁÂÀå : ±è¼®¿µ(°¡ÃµÀÇ´ë)
OB1711:40~11:50 ±è¹Î¾Æ
¿¬¼¼ÀÇ´ë °­³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
The influence of disease activity on birth outcomes in women with irritable bowel disease: Meta-analysis
OB1811:50~12:00 À±ÁÖÇö
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐºÎ¼Ó ¸ñµ¿º´¿ø »êºÎÀΰú
Differential effect of food restriction during gestation or lactation period on changes in enzymes associated with hepatic lipid metabolism in male rat pups
OB1912:00~12:10 Á¤½Å¿Á
Simple high-throughput analytical method using ultra-performance liquid chromatography coupled with tandem mass spectrometry for quantifying total NNAL in early pregnant women
OB2012:10~12:20 ÇѼºÈñ
(Àç)¼­¿ïÀÇ°úÇבּ¸¼Ò
Clinical application of noninvasive prenatal test (NIPT) for fetal chromosomal aneuploidy by maternal plasma DNA sequencing: The first experience in Korea
OB21-OB24 (12:20~13:00) ÁÂÀå : È«±â¿¬(¿ø±¤ÀÇ´ë)
OB2112:20~12:30 ½É¼ÒÇö
Â÷ÀÇ°úÇдëÇб³ °­³²Â÷º´¿ø »êºÎÀΰú
Mullerian anomaly°¡ ÀÖ´Â ¿©¼º¿¡¼­ÀÇ ½ÖÅÂÀӽſ¡ °üÇÑ ¿¬±¸
OB2212:30~12:40 ±ÇÁ¤Àº
¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú
»ïÅÂ¾Æ Àӽſ¡¼­ ÀӽŹæ¹ý¿¡ µû¸¥ Á¢ÇÕ¼º°ú ÀӽŠÁß ÇÕº´ÁõÀÇ Â÷ÀÌ
OB2312:40~12:50 ±è¹Î¾Æ
¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú
35¼¼ ÀÌ»óÀÇ °í·É ½ÖÅÂÀÓ½ÅÀÇ ÁÖ»ê±â ¿¹ÈÄ
OB2412:50~13:00 ¹ÚÇö¼ö
µ¿±¹ÀÇ´ë Àϻ꺴¿ø »êºÎÀΰú
ȸÀ½Àý°³ÀÇ À¯¹«¿¡ µû¸¥ 3µµ ¿­»ó ¹ß»ýÀÇ ºñ±³
OB25-OB29 (14:00~14:50) ÁÂÀå : ±è±¤ÁØ(Áß¾ÓÀÇ´ë)
OB2514:00~14:10 ¿°Á¤ÀÎ
¾ç»êºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú
Differential expression of steroid hormone coactivators in the human placenta complicated with preeclampsia
OB2614:10~14:20 ¹ÚÁöÀº
°æ»ó´ëÇб³º´¿ø »êºÎÀΰú
Analysis of Increased Nuchal Translucency: Experience of a Single University Hospital
OB2714:20~14:30 ÁøÇý¹Ì
°í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú
Maternal MgSO4 treatment during pregnancy does not affect offspring¡¯s bone
OB2814:30~14:40 À̽ÂÇü
°¡ÃµÀÇ´ë ±æº´¿ø »êºÎÀΰú
Clinical profiles and outcomes in peripartum cardiomyopathy
OB2914:40~14:50 ¹ÚÁö±Ç
°æ»ó´ëÇб³º´¿ø »êºÎÀΰú
The modified Shirodkar procedure for rescue cervical cerclage: effective alternative to the McDonald suture